Cranio : the journal of craniomandibular practice · 2026
Otologic manifestations of temporomandibular disorders: effects of TMJ arthrocentesis.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Çoban Elif, Çıracı Zehra Beyza, Bilgin Mert
Аннотация
INTRODUCTION: A bidirectional interaction may exist between temporomandibular disorders (TMD) and otologic symptoms. This study aimed to evaluate changes in patient-reported otologic symptoms following temporomandibular joint (TMJ) arthrocentesis.
MATERIALS AND METHODS: This retrospective cohort study included 40 patients who underwent TMJ arthrocentesis. Demographic data, TMJ-related clinical findings, otologic symptoms, and visual analog scale (VAS) scores were assessed preoperatively and at a 30-day follow-up.
RESULTS: .The majority of patients were female (82.5%), with a mean age of 35.4 ± 11.03 years. Significant reductions were observed in otalgia and tinnitus after arthrocentesis (p < .05). No significant changes were detected in hearing loss or vertigo (p > .05). VAS scores showed significant improvement in TMD symptoms, otalgia, and tinnitus, while hearing loss and vertigo remained unchanged.
CONCLUSION: TMJ arthrocentesis was associated with subjective improvement in otalgia and tinnitus in patients with TMD, whereas hearing loss and vertigo showed no significant change.
MATERIALS AND METHODS: This retrospective cohort study included 40 patients who underwent TMJ arthrocentesis. Demographic data, TMJ-related clinical findings, otologic symptoms, and visual analog scale (VAS) scores were assessed preoperatively and at a 30-day follow-up.
RESULTS: .The majority of patients were female (82.5%), with a mean age of 35.4 ± 11.03 years. Significant reductions were observed in otalgia and tinnitus after arthrocentesis (p < .05). No significant changes were detected in hearing loss or vertigo (p > .05). VAS scores showed significant improvement in TMD symptoms, otalgia, and tinnitus, while hearing loss and vertigo remained unchanged.
CONCLUSION: TMJ arthrocentesis was associated with subjective improvement in otalgia and tinnitus in patients with TMD, whereas hearing loss and vertigo showed no significant change.